International Law & Trade, Health Law, Intellectual Property

News from Abroad: Bill to Diminish Term of Patents for Medicaments

by McDonnell Boehnen Hulbert & Berghoff LLP on 3/6/2013

Originally published in Olivares & Cia. on March 4, 2013. In January, the Mexican Senate published a Bill adding article 23 bis to the Industrial Property Law (IP Law). This Bill intends to establish a "special" life...more

January 2013: European Litigation Update

by Quinn Emanuel Urquhart & Sullivan, LLP on 2/6/2013

The European Court of Justice (ECJ) on European Supplementary Protection Certificate (SPC) for Further Medical Uses: With a remarkable ruling from July 2012 (Neurim Pharmaceuticals, C-130/11), the European Court of Justice...more

China Trade Marks – Inclusion of Retail and Wholesale services relating to medicines and pharmaceuticals

by Jonathan Feder, Shalini Jayaweera, Anthony Watson | K&L Gates LLP on 1/21/2013

The China Trade Marks Office (CTMO) recently announced that from 1 January 2013 it is accepting applications to register trade marks in relation to retail or wholesale services for pharmaceutical, veterinary and sanitary...more

China Issues Human Genetic Resources Management Regulations

by Foley & Lardner LLP on 11/19/2012

Those seeking to conduct research involving human genetic material within the People’s Republic of China or to import into China such material should review China’s recently issued draft regulations (“Draft”) for the...more

"The Global Competition Landscape: A Conversation With Sharis Pozen"

by Skadden, Arps, Slate, Meagher & Flom LLP on 10/25/2012

Skadden recently welcomed Sharis A. Pozen, former Acting Assistant Attorney General of the Antitrust Division of the U.S. Department of Justice, as a new partner in the firm’s Washington, D.C. office. Sharis discusses her DOJ...more

Russia's Accession to the WTO: Benefits and Risks

by Armstrong Teasdale LLP on 8/29/2012

On August 22, 2012, the World Trade Organization welcomed Russia as its 156th member. As a result, Russia will lower its tariffs on imports of goods across all sectors of the economy and will reduce trade barriers. This will...more

China 20/20 Legal and Regulatory Developments - April 27, 2012

by Orrick, Herrington & Sutcliffe LLP on 4/27/2012

In This Issue: - Measures to Supervise Overseas Investments of Central Enterprises - Provisions Governing Overseas Manufacturers of Imported Food - China to Amend Measures for Foreign Invested Medical...more

"Skadden's 2012 Insights, January 2012: Global Litigation"

by Skadden, Arps, Slate, Meagher & Flom LLP on 1/12/2012

In This Issue: - 58 U.S. Supreme Court Cases to Watch - 59 Securities Litigation: Recent Supreme Court Decisions and Future Trends - 66 Continued Step-up in Government Investigations and White Collar Crime...more

WTO Accession of the Russian Federation - Implications for Pharmaceuticals and Medical Devices

by King & Spalding on 12/22/2011

Russia’s accession to the World Trade Organization (WTO) will create opportunities to increase exports of pharmaceutical products and medical devices. On 16 December 2011, WTO Members accepted the terms of the Russian...more

Trade Remedies Are Being Used to Combat Imports of Infringing Medical Devices

by King & Spalding on 5/2/2011

Medical device cases are being filed with increasing frequency at the U.S. International Trade Commission (ITC) to combat infringing imports. In particular, owners of intellectual property rights on medical devices regularly...more

Patent Opposition in India: Recent Trends

by Rahul Dev on 1/12/2010

Therefore, as may be seen, the two-stage patent opposition process has particularly affected the pharmaceutical industry, as the patent applicants are now vulnerable to multiple pre-grant oppositions filed by competitors, or...more

Pharmaceutical Patent Settlements Under Fire on Both Sides of the Atlantic

by Morrison & Foerster LLP on 7/22/2009

In recent weeks, the pharmaceutical industry has been in the crosshairs of antitrust enforcers in the U.S. and in Europe. Specifically, patent litigation settlements in which a brand pharmaceutical manufacturer makes a...more

European Commission's Pharmaceutical Sector Inquiry Report Finds Certain Practices May Delay Entry of Generic Medicines

by Morrison & Foerster LLP on 12/2/2008

On November 28, 2008, the European Commission published its preliminary report and findings in connection with the sector inquiry it launched late last year on competition in the pharmaceutical sector. The Commission...more

Intellectual Property Advisory: Patentability of Dosage Regimens at the EPO and in the UK

by Mintz Levin - Intellectual Property on 7/16/2008

It has long been established that second (and further) medical uses of a known medicament may be patented at the European Patent Office (EPO) and in the UK, provided that appropriate claim formats are used, including those...more

European Commission Raids Pharmaceutical Companies to Start Sector Inquiry

by Morrison & Foerster LLP on 1/17/2008

On January 16, 2008, the European Commission launched a sector inquiry into the pharmaceuticals industry by carrying out a series of unannounced inspections of innovative and generic pharmaceutical companies. The targeted...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

International Law & Trade › Health Law › Intellectual Property